Your session is about to expire
← Back to Search
Sensor
MicroTrend System for Low Blood Flow
N/A
Waitlist Available
Led By Raul J Gazmuri, MD, PhD
Research Sponsored by ExoStat Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 hours
Awards & highlights
Study Summary
This trial is testing a new system that monitors carbon dioxide levels in the blood, to see if it is safe and effective.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-6 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation between POMCO2
Trial Design
1Treatment groups
Experimental Treatment
Group I: MicroTrend SystemExperimental Treatment1 Intervention
MicroTrend System is placed onto the subject's cheek and the subject will actively participate in the study for up to 6 hours, with up to 4 hours of sensor monitoring.
Find a Location
Who is running the clinical trial?
ExoStat Medical, Inc.Lead Sponsor
Bright Research PartnersIndustry Sponsor
13 Previous Clinical Trials
1,747 Total Patients Enrolled
Raul J Gazmuri, MD, PhDPrincipal InvestigatorCaptain James A. Lovell Federal Health Care Center
Share this study with friends
Copy Link
Messenger